Results with Lifescozul™
Introduction to the case
Medulloblastoma is a brain tumor that can occur in both children and adults, but is more common in children. In the case of adults, it usually affects people between 20 and 40 years of age.
All Medulloblastomas are classified as grade IV tumors, meaning they are malignant and tend to grow very fast.
In March 2017, Enrique was diagnosed with a posterior fossa Medulloblastoma. In May 2017 he underwent surgery to remove the tumor and subsequently started radiotherapy and chemotherapy sessions.
In April 2018 it is confirmed through an MRI that there is recurrence of the disease with a tumor in the posterior region of cerebellum.
She received Gamma Knife radiosurgery treatment in June 2018 and continued chemotherapy sessions, showing tumor shrinkage.
While looking for a treatment for his father-in-law, who also had cancer at the time, he found LifEscozul Group.
Enrique started with our treatment in January 2019, let's learn more about his case and see what results he achieved with LifEscozul (the most effective formulation made with blue scorpion venom).
-
Clinical Data
Enrique Julian Arrascue Diaz, 34 years old at the beginning of treatment with LifEscozul.
-
Symptomatology
Sudden but short tinnitus, occasional head discomfort in the parietal area and others in the primary lesion area.
-
Protocol Start
January 2019.
-
Specialist assigned to Grupo LifEscozul™
Dr. Aaron Sarmiento
-
Diagnostics
Grade IV medulloblastoma brain tumor, located in posterior fossa.
Background
Enrique was in severe pain and was rushed to the hospital. While there he fell to his knees due to the poor condition he was in.
In March 2017 he was diagnosed with a Medulloblastoma in the posterior fossa (which is a small space in the skull that is close to the brainstem and cerebellum).
In May 2017, he underwent a craniotomy (which is a surgery that involves surgically removing part of the skull bone to expose the brain) to remove the nodule, resulting in WHO IV medulloblastoma pathology. It is important to note that brain tumors are classified into WHO (World Health Organization) grades. Like the differentiation grades of the other tumors, grade 4 (IV) tumors are the most aggressive.
After this surgery he was prescribed radiotherapy and 12 sessions of Vincristine chemotherapy (which is an anticancer chemotherapy drug).
Due to the side effects of the chemotherapy (intoxication and numbness of the feet) Enrique was only able to endure 6 sessions and then decided to abandon this treatment.
Unfortunately, in April 2018 it is confirmed by an MRI that there is a recurrence of the disease, the tumor was in the posterior region of cerebellum.
In June 2018 he underwent radiosurgery with Gamma Knife, then he was prescribed 8 sessions of adjuvant chemotherapy with Lomustine (which is a drug used to treat certain types of brain tumors) and at the same time he continued with medical controls. With this treatment the tumor showed a reduction.
While Enrique was looking for a treatment for his father-in-law, who unfortunately died of a very aggressive cancer shortly after, he found the LifEscozul Group. What caught his attention and what convinced him to contact us was that our website was the only one with proven results.
After sending us all his medical documentation for us to evaluate his case, in January 2019 Enrique started with the LifEscozul treatment (escozul, blue scorpion venom, escoazul).
Evolution with LifEscozul™ and actual results
FEBRUARY AND MARCH 2019
Enrique has always been in constant contact with Dr. Aaron Sarmiento, which has allowed us to follow up his case.
Since the beginning of the treatment with LifEscozulla (the most effective formulation made with blue scorpion venom), Enrique reported that he felt very positive effects.
The PET-CT results sent by Enrique in the months of February and March 2019, showed that there was a metabolic remission of the lesion, which means that the tumor has less cancerous activity.
During the following months Enrique reported to us that he was feeling very well and that he would continue with the respective periodic controls.
OCTOBER 2019
By October 2019 a new PET-CT scan indicated that the disease continued at the same size and no tumor activity was reported.
Despite having been diagnosed a year and 6 months ago with a very aggressive tumor (WHO IV), Enrique's medical results were very encouraging.
MARCH TO OCTOBER 2020
5 months after the last PET-CT Enrique is a different man, he feels more energetic and encouraged and those who know him cannot believe that he is an oncology patient because of the excellent condition he is in.
According to the last PET-CT report performed in March 2020, it indicates that there is no presence of cancer.
In addition, in the area where the lesion was previously described, changes of a sequelae nature are now described.
Due to the pandemic, access to treatment with LifEscozul (escozul, blue scorpion venom, escoazul) has been somewhat complicated, which is an issue that we are working on with him and with other of our patients in order to get the product to them as soon as possible.
In spite of having gone a few months without our treatment, he has not presented any significant symptoms of his disease.
Additionally, Enrique also told us that since he started taking the LifEscozul treatment (the most effective formulation made with blue scorpion venom) he feels that his glucose levels have been controlled, taking into account that he is diabetic. During this time it has not been necessary for him to take medication for this disease and he has only controlled it with diet. This point will be thoroughly evaluated by our Medical Team.
Due to the chemotherapy with Vincristine Enrique felt numbness in his feet, but this symptom was reduced by 95%.
From time to time he feels muscle pain all over his body, which is a side effect of the Lomustine chemotherapy.
His doctors had told him that as a result of the craniotomy it was likely that he would eventually be unable to care for himself, but to date he has not had any side effects from this surgery.
His case will continue to be monitored by our Medical Team for another 5 years.
Resumen
In March 2017 Enrique is diagnosed with a Medulloblastoma, and in May 2017 he underwent surgery to remove the grade 4 tumor. He was subsequently prescribed radiation therapy and 12 sessions of Vincristine chemotherapies.
The side effects of the chemotherapy were very strong and Enrique was only able to endure 6 sessions. In April 2018 it was confirmed by MRI that the disease returned, and in June 2018 he received treatment with radiosurgery.
He was subsequently prescribed adjuvant chemotherapy and with this treatment the tumor showed a reduction.
While Enrique was looking for a treatment for his father-in-law he found LifEscozul Group, and in January 2019 Enrique started with LifEscozul treatment (escozul, blue scorpion venom, escoazul).
1 year and 2 months after starting with our treatment Enrique reported to us that according to the results of his last PET-CT, performed in March 2020, it is indicated that there is no presence of cancer.
According to his own words: "As a blessing from heaven I found LifEscozul and it has helped me to keep cancer and even other ailments at bay, very recommendable and definitely harmless to the organism".
Enrique managed to overcome all his prognoses, he is a person with a lot of faith and desire to move forward, he also enjoys very good health and is in good spirits. He is currently monitored only with PET-Scan and if a nodule appears, the treatment with LifEscozul (the most effective formulation made with blue scorpion venom) fights it.
Our Medical Team will continue to follow up your case.
We are the LifEscozul Group and the Results Define Us.
Next case
Raúl Manzano Murillo
Raul was detected with thyroid cancer in 2016 and underwent surgery in April 2016 for papillary thyroid carcinoma. At the end of 2017 he was detected new tumor nodules on both sides of his neck, with no possibility of operation due to fibrosis following surgery and iodotherapies received, he was offered no treatment option. View more
